Literature DB >> 6235414

Hematoporphyrin derivative and photoradiation therapy in early stage lung cancer.

Y Hayata, H Kato, C Konaka, J Ono, R Amemiya, K Kinoshita, H Sakai, R Yamada.   

Abstract

Photoradiation therapy (PRT) with administration of hematoporphyrin derivative (HPD) was performed in ten cases of early stage central-type lung cancer of which six cases were treated by PRT alone due to inoperability because of poor pulmonary function in five and refusal of surgery in one. Four cases were resected after PRT. In the former, complete tumor remission was obtained in all six and in the latter, complete tumor remission was seen in one and significant remission in three. In the nonresected cases four cases are disease-free at 17-41 months and the remaining two cases died of chronic obstructive lung disease and cerebral infarction 16 and 31 months after PRT, respectively. The resected cases are disease-free 7-32 months after surgery. Indications of PRT in early stage lung cancer are discussed according to histological findings of resected specimen.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6235414     DOI: 10.1002/lsm.1900040106

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  2 in total

Review 1.  Diagnostic and therapeutic bronchoscopy.

Authors:  R S Tharratt; A Chan
Journal:  Clin Rev Allergy       Date:  1990 Summer-Fall

2.  Hematoporphyrin derivative and anthracyclines mutually inhibit cellular uptake and toxicity.

Authors:  R M Böhmer; K Hoffmann; G Morstyn
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.